TowerBrook Capital Partners

TowerBrook Capital Partners is a New York-based private equity firm that describes itself as purpose-driven, with healthcare investing concentrated in care delivery and tech-enabled services platforms intended to deliver measurable societal impact. The firm operates internationally and often pursues complex, larger transactions that combine financial returns with broader stakeholder considerations. TowerBrook is not specifically positioned as an AI investor, but technology-enabled service models inside its healthcare portfolio frequently rely on data and automation. Founders should expect substantive diligence on impact, governance, and alignment with the firm’s stated purpose framework.

Investments occur at the growth stage with check sizes of $25M and above, encompassing both control buyouts and significant minority structures. TowerBrook’s footprint spans North America and Europe, giving it the ability to support transatlantic expansion. Healthcare opportunities of interest tend to involve provider organizations, multi-site clinical platforms, and services businesses with operational scale and clear opportunities for margin and quality improvement.

Founders should approach TowerBrook with a clear articulation of clinical outcomes, workforce considerations, and financial fundamentals. Pitches that present AI as a means to improve clinician throughput, patient access, or quality of care will resonate better than purely technology-centered narratives. Given the firm’s larger-deal orientation, smaller companies are more likely to fit through portfolio add-on acquisitions than as standalone platform investments, so research into existing TowerBrook holdings can sharpen positioning.